Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 06, 2016 7:37 AM ET

Healthcare Equipment and Supplies

Company Overview of Cognoptix, Inc.

Company Overview

Cognoptix, Inc. operates as a medical technology company that creates and develops a non-invasive eye scanning test for the early detection and diagnosis of Alzheimer’s disease. It also develops combined optical scanning devices and diagnostic agents for clinical, commercial, and academic research use. Cognoptix, Inc. was formerly known as Neuroptix Corporation and changed its name to Cognoptix, Inc. in October 2012. The company was founded in 2001 and is based in Acton, Massachusetts.

20 Main Street

Acton, MA 01720

United States

Founded in 2001

Phone:

978-263-0005

Fax:

978-263-0015

Key Executives for Cognoptix, Inc.

Chief Executive Officer
Age: 63
Co-Founder
Chief Financial Officer
Director of Research and Development
Compensation as of Fiscal Year 2015.

Cognoptix, Inc. Key Developments

Cognoptix Appoints Barry D. Greenberg to Clinical Advisory Board

Cognoptix announced that it has appointed Barry D. Greenberg, Ph.D., to its clinical advisory board. Dr. Greenberg is Director of Neuroscience Drug Discovery & Development at University Health Network, Toronto; and, Director of Strategy, Toronto Dementia Research Alliance. Expansion of the Cognoptix Clinical Advisory board follows an announcement by the company on Sept. 30, 2014, that it has closed the first tranche of a Series D round of financing totaling over $15 million.

Cognoptix Announces Board Appointments

Cognoptix announced that it has elected its President and CEO, Paul D. Hartung, as Chairman of the Board. The company also announced that it has elected a new director: Christine de los Reyes, PharmD, Vice President, Business Development and Strategic Planning, Alopexx Enterprises LLC. Dr. Christine de los Reyes is Vice President of Business Development and Strategic Planning at Alopexx Enterprises. Most recently, she was founder and Managing Director of BiotechPartnering Solutions.

Cognoptix, Inc. Presents at 9th Annual The Neurotech Investing & Partnering Conference 2014, Apr-23-2014 10:30 AM

Cognoptix, Inc. Presents at 9th Annual The Neurotech Investing & Partnering Conference 2014, Apr-23-2014 10:30 AM. Venue: The Ritz Carlton, 10 Avery St., Boston, Massachusetts, United States. Speakers: Paul Hartung, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
INOVA Diagnostics, Inc. United States
Cardiac Surgical Devices, Inc. United States
CalHealth, Inc. United States
Rhaphis Medical Inc. United States
Hamilton Robotics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cognoptix, Inc., please visit www.cognoptix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.